Sox6 impairs the adipogenic commitment of mesenchymal stem cells by targeting lysyl oxidase and preadipocyte factor 1
Biochemical and Biophysical Research Communications · 2023
DOI: 10.1016/j.bbrc.2023.09.084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Shao-Yue Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai Pudong Hospital, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 201399, China. Hauptthemen laut MEDLINE: Adipogenesis, Mesenchymal Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Fudan University.
Abstract (Originalsprache)
The commitment of mesenchymal stem cells (MSCs) to preadipocytes and the termination of differentiation to adipocytes are critical for maintaining systemic energy homeostasis. However, our knowledge of the molecular mechanisms governing the commitment of MSCs to preadipocytes and the subsequent termination of their differentiation into adipocytes remain limited. Additionally, the role of Sox6 sex-determining region Y (SRY)-box6 (Sox6), a transcription factor that regulates gene transcription, is reportedly involved in various cellular processes, including adipogenesis; however, its function in regulating preadipocyte development and the factors involved in the termination of adipogenic differentiation remain unexplored. Therefore, we investigated the role of Sox6 in regulating the differentiation of adipocytes by monitoring the effects of its overexpression in C3H10T1/2 cells (in vitro) and C57BL/6J mouse (in vivo) models of adipogenesis. We observed lower Sox6 expression in the adipose tissue of obese mice than that in control mice. Sox6 overexpression inhibited the differentiation of MSC by directly binding to the lysyl oxidase (Lox) and preadipocyte factor 1 (Pref1) promoters, which was potentiated by histone deacetylase-1(HDAC1). Our findings suggest that Sox6 is a key regulator of MSC commitment to adipocytes; therefore, targeting the Sox6-mediated regulation of this process could offer potential therapeutic avenues for addressing obesity and related metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shanghai Pudong Hospital, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 201399, China.
- Department of Clinical Laboratory, Shanghai Pudong Hospital, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 201399, China. Electronic address: changdongydy@163.com.
- Department of Clinical Laboratory, Shanghai Pudong Hospital, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 201399, China. Electronic address: xucongjian@fudan.edu.cn.
- Department of Clinical Laboratory, Shanghai Pudong Hospital, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 201399, China. Electronic address: douxin0301@163.com.
Förderung
- Fudan University
Zitieren
APA
Du, S. Y., Hu, L., Zhou, B. H., Zhang, Z., Li, M. C., Chang, D., Xu, C. J., & Dou, X. (2023). Sox6 impairs the adipogenic commitment of mesenchymal stem cells by targeting lysyl oxidase and preadipocyte factor 1. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.09.084
Vancouver
Du SY, Hu L, Zhou BH, Zhang Z, Li MC, Chang D, et al. Sox6 impairs the adipogenic commitment of mesenchymal stem cells by targeting lysyl oxidase and preadipocyte factor 1. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.09.084
BibTeX
@article{Du2023,
author = {Du, Shao-Yue and Hu, Liang and Zhou, Bing-He and Zhang, Ze and Li, Ming-Chao and Chang, Dong and Xu, Cong-Jian and Dou, Xin},
title = {Sox6 impairs the adipogenic commitment of mesenchymal stem cells by targeting lysyl oxidase and preadipocyte factor 1},
journal = {Biochemical and Biophysical Research Communications},
year = {2023},
doi = {10.1016/j.bbrc.2023.09.084}
}
EUVIMED